• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GALDERMA Q-MED AB SCULPTRA IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GALDERMA Q-MED AB SCULPTRA IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Lot Number 0J48D1
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Erythema (1840); Hypersensitivity/Allergic reaction (1907); Angioedema (4536); Swelling/ Edema (4577); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 11/25/2021
Event Type  Injury  
Manufacturer Narrative
Company comment:the serious events of angioedema, hypersensitivity at implant site and pharyngeal oedema and the non-serious events of swelling and erythema at implant site were considered expected and possibly related to the treatment. Serious criteria included the need for urgent medical care including medical intervention with adrenaline to prevent a life threatening condition or permanent damage. The likely root cause include the patient's hypersensitivity to the product. The case meets the criteria for expedited reporting to the regulatory authorities. Product note: routine investigations have been performed and indicate a possible involvement of the product. The reported lot number was valid and verified the reported product. No previous medical complaints have been reported on the specified lot number. However, a repeated batch record review will be conducted to exclude a non-conforming product.
 
Event Description
(b)(4) is a spontaneous report sent on 26-nov-2021 by a physician concerning a (b)(6) female patient. Additional information was received on (b)(6) 2021 from the same reporter. No information about medical history, concomitant medication, history of allergies or previous filler treatments has been provided. On (b)(6) 2021, the patient received treatment with sculptra (lot 0j48d1) to face (unknown amount, injection technique and needle type). On (b)(6) 2021, after receiving sculptra injection, while returning home, the patient experienced allergic crisis (implant site hypersensitivity). The patient went to the hospital and was under observation. The patient experienced angioedema (angioedema), face swelling (implant site swelling), red skin stains (implant site erythema) and throat closed (pharyngeal oedema) as reported. On (b)(6) 2021, the patient received corrective treatment with adrenaline [epinephrine] and an unspecified corticoid [corticosteroid nos]. On (b)(6) 2021, the patient was discharged from the hospital observation and was already at home. The patient's hospitalization lasted 8 hours. On (b)(6) 2021, the patient had a medical appointment with an allergist who requested some lab tests and oriented the patient to continue using corticoid until the acknowledge of tests results. At the time of report, the patient was still using corticoid. The reporting physician informed that the patient was stable and recovering. Outcome at the time of the report: angioedema was recovering/resolving. Allergic crisis was recovering/resolving. Swelling was recovering/resolving. Red skin stains was recovering/resolving. Throat closed was recovering/resolving. Tracking list: v. 0 initial v. 1 fu received on 30-nov-2021 from the same reporter: duration of hospitalization, outcome of events, corrective treatment and laboratory test details were updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameSCULPTRA
Type of DeviceIMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
GALDERMA Q-MED AB
seminariegatan 21
uppsala, SE-75 228
SW SE-75228
Manufacturer (Section G)
GALDERMA Q-MED AB
seminariegatan 21
uppsala, SE-75 228
SW SE-75228
Manufacturer Contact
randy russell
14501 n. freeway
fort worth, TX 76177
MDR Report Key12940206
MDR Text Key286121186
Report Number9710154-2021-00076
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030050S002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation
Type of Report Initial
Report Date 12/06/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/06/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Device Lot Number0J48D1
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/26/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/11/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unkown

Patient Treatment Data
Date Received: 12/06/2021 Patient Sequence Number: 1
-
-